Healthcare provider profile · identity verified

Peter B Blankenhorn, MD

Internal Medicine · INDIANAPOLIS, IN · NPI 1235103615

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1146	346
Amlodipine Besylate	Amlodipine Besylate	813	239
Levothyroxine Sodium	Levothyroxine Sodium	543	150
Losartan Potassium	Losartan Potassium	523	164
Metoprolol Succinate	Metoprolol Succinate	456	141
Lisinopril	Lisinopril	426	126
Hydrochlorothiazide	Hydrochlorothiazide	357	105
Omeprazole	Omeprazole	349	103
Pantoprazole Sodium	Pantoprazole Sodium	347	102
Rosuvastatin Calcium	Rosuvastatin Calcium	334	109
Gabapentin	Gabapentin	277	97
Simvastatin	Simvastatin	268	75
Tamsulosin Hcl	Tamsulosin Hcl	252	75
Metformin Hcl	Metformin Hcl	246	73
Metformin Hcl Er	Metformin Hcl	220	72
Furosemide	Furosemide	207	60
Trazodone Hcl	Trazodone Hcl	205	62
Pravastatin Sodium	Pravastatin Sodium	182	58
Sertraline Hcl	Sertraline Hcl	165	45
Allopurinol	Allopurinol	164	50
Montelukast Sodium	Montelukast Sodium	163	48
Potassium Chloride	Potassium Chloride	157	39
Metoprolol Tartrate	Metoprolol Tartrate	150	43
Eliquis	Apixaban	148	46
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	147	42
Jardiance	Empagliflozin	139	42
Clopidogrel	Clopidogrel Bisulfate	135	38
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	133	40
Meloxicam	Meloxicam	129	45
Fluticasone Propionate	Fluticasone Propionate	124	56
Tramadol Hcl	Tramadol Hcl	110	13
Carvedilol	Carvedilol	109	38
Albuterol Sulfate Hfa	Albuterol Sulfate	107	40
Zolpidem Tartrate	Zolpidem Tartrate	105	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	30
Ozempic	Semaglutide	103	22
Celecoxib	Celecoxib	92	26
Duloxetine Hcl	Duloxetine Hcl	92	25
Synthroid	Levothyroxine Sodium	92	24
Fluoxetine Hcl	Fluoxetine Hcl	89	23
Valsartan	Valsartan	88	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	25
Famotidine	Famotidine	86	19
Escitalopram Oxalate	Escitalopram Oxalate	85	31
Alprazolam	Alprazolam	83	19
Bupropion Xl	Bupropion Hcl	74	19
Hydralazine Hcl	Hydralazine Hcl	74	23
Alendronate Sodium	Alendronate Sodium	69	19
Glipizide Er	Glipizide	67	20
Meclizine Hcl	Meclizine Hcl	65	24
Olmesartan Medoxomil	Olmesartan Medoxomil	65	19
Clonidine Hcl	Clonidine Hcl	64	17
Finasteride	Finasteride	64	19
Irbesartan	Irbesartan	63	16
Citalopram Hbr	Citalopram Hydrobromide	61	17
Atenolol	Atenolol	58	18
Benazepril Hcl	Benazepril Hcl	57	14
Clonazepam	Clonazepam	54	suppressed
Januvia	Sitagliptin Phosphate	53	15
Ezetimibe	Ezetimibe	51	16
Triamcinolone Acetonide	Triamcinolone Acetonide	51	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	51	15
Warfarin Sodium	Warfarin Sodium	49	12
Donepezil Hcl	Donepezil Hcl	47	11
Buspirone Hcl	Buspirone Hcl	46	14
Glimepiride	Glimepiride	44	13
Nifedipine Er	Nifedipine	44	suppressed
Spironolactone	Spironolactone	43	15
Venlafaxine Hcl Er	Venlafaxine Hcl	43	14
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Valacyclovir	Valacyclovir Hcl	39	19
Acyclovir	Acyclovir	38	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Mounjaro	Tirzepatide	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Glipizide	Glipizide	34	11
Hydrocortisone	Hydrocortisone	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Diazepam	Diazepam	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Estradiol	Estradiol	32	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	32	32
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	11
Indapamide	Indapamide	29	suppressed
Mirtazapine	Mirtazapine	29	11
Temazepam	Temazepam	29	suppressed
Klor-Con M20	Potassium Chloride	28	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	26
Ondansetron Odt	Ondansetron	28	13
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Linzess	Linaclotide	24	suppressed
Nystatin	Nystatin	24	suppressed
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Torsemide	Torsemide	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Methylprednisolone	Methylprednisolone	20	19
Verapamil Er	Verapamil Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	12
Ibuprofen	Ibuprofen	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Ramipril	Ramipril	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Azithromycin	Azithromycin	16	15
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Prednisone	Prednisone	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Colchicine	Colchicine	11	suppressed
Combipatch	Estradiol/Norethindrone Acet	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error